[Drug-coated balloons versus bare metal stent for treatment of femoropopliteal lesions:36 month follow-up results of single center]

Zhonghua Wai Ke Za Zhi. 2021 Dec 1;59(12):975-979. doi: 10.3760/cma.j.cn112139-20210902-00415.
[Article in Chinese]

Abstract

Objective: To examine the therapeutic effects of drug-coated balloon (DCB) and bare metal stent (BMS) on primary femoropopliteal disease (FPAD) in the real world. Methods: This was a retrospective analysis of single-center follow-up results at 12,24,and 36 months of patients with FPAD lesions that were treated with DCB and BMS at Department of Aortic and Vascular Surgery, Fu Wai Hospital.One-to-one propensity score matching(PSM) was performed to balance the covariance between DCB group (137 cases) and BMS group (100 cases). Freedom from clinically driven target lesion reintervention rate(fCD-TLR) was determined by Kaplan-Meier curve.Log-rank test was used to compare the rates of fCD-TLR between DCB and BMS groups at 12,24,36 months post-operation. Results: After PSM, there were both 71 patients in each group,aged (68.0±9.6) years(range: 46 to 90 years) and (68.8±7.3) years(range: 48 to 87 years),lesion lengths were (119.6±14.2)mm(range:40 to 380 mm) and (110.8±13.1)mm(range:40 to 400 mm). The median follow-up period were 24.3 months (range:5.8 to 55.1 months).There was no death,amputation or reintervention within the 30 days after operation.The rates of fCD-TLR for DCB group at 12,24 and 36 months were 97.2%,85.9%,69.1%, and 95.8%,83.1%,59.2% for BMS group.There was no statistical difference between the two groups by Log-rank test (P=0.551). Conclusion: DCB and BMS can both maintain favorable clinical effects in FPAD patients at 12,24,36 months post-operation.

目的: 比较药物涂层球囊(DCB)和金属裸支架(BMS)治疗股腘动脉原发病变的临床效果。 方法: 回顾性分析2015年12月至2020年12月于阜外医院血管外科中心行DCB或BMS治疗的股腘动脉原发病变患者的临床资料。采用倾向性评分匹配法对DCB组(137例)和BMS组(100例)患者进行1∶1最邻近匹配。应用Kaplan-Meier曲线和Log-rank检验比较两组患者12、24、36个月免于临床驱动的靶病变血运重建率(fCD-TLR),评价DCB和BMS治疗股腘动脉病变效果的差异。 结果: 匹配后两组各71例,年龄分别为(68.0±9.6)岁(范围:46~90岁)和(68.8±7.3)岁(范围:48~87岁),病变长度分别为(119.6±14.2)mm(范围:40~380 mm)和(110.8±13.1)mm(范围:40~400 mm)。术后中位随访时间24.3个月(范围:5.8~55.1个月),DCB和BMS组患者术后30 d均未出现死亡、截肢、再干预等情况。DCB组12、24、36个月的fCD-TLR分别为97.2%、85.9%、69.1%,BMS组分别为95.8%、83.1%、59.2%,Log-rank检验结果显示,组间fCD-TLR的差异无统计学意义(P=0.551)。 结论: 对于股腘动脉病变,DCB和BMS两种治疗方式在术后12、24、36个月内均可维持较好的治疗效果。.

MeSH terms

  • Angioplasty, Balloon*
  • Coated Materials, Biocompatible
  • Femoral Artery
  • Follow-Up Studies
  • Humans
  • Peripheral Arterial Disease*
  • Pharmaceutical Preparations*
  • Popliteal Artery
  • Retrospective Studies
  • Stents
  • Treatment Outcome
  • Vascular Patency

Substances

  • Coated Materials, Biocompatible
  • Pharmaceutical Preparations